Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.97 USD
Change Today -0.19 / -1.87%
Volume 762.1K
SGMO On Other Exchanges
Symbol
Exchange
SGMO is not on other exchanges.
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for sangamo biosciences inc (SGMO)

Sangamo Biosciences Inc. uses little or no debt in its capital structure and may have less financial risk than the industry aggregate. Accounts Receivable are typical for the industry, with 53.80 days worth of sales outstanding.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Dec 31
2013
Reclassified
Dec 31
2014
4 Year
Trend
Assets    
Cash and Equivalents16.821.710.26.0
Short-Term Investments67.441.982.6172.9
TOTAL CASH AND SHORT TERM INVESTMENTS84.163.592.8179.0
Accounts Receivable0.94.13.210.4
Other Receivables0.30.20.30.4
TOTAL RECEIVABLES1.34.33.510.8
Prepaid Expenses0.30.30.50.6
Restricted Cash----0.30.3
Other Current Assets--0.20.20.2
TOTAL CURRENT ASSETS85.768.497.3190.9
Gross Property Plant and Equipment4.34.54.95.4
Accumulated Depreciation-2.7-3.0-3.5-3.9
NET PROPERTY PLANT AND EQUIPMENT1.61.51.41.5
Goodwill----1.61.6
Long-Term Investments--12.638.747.3
Other Intangibles----1.91.9
Other Long-Term Assets0.00.00.00.1
TOTAL ASSETS87.382.5140.8243.2
    
LIABILITIES & EQUITY    
Accounts Payable4.13.03.05.5
Accrued Expenses2.93.34.45.8
Other Current Liabilities, Total0.10.10.40.5
Unearned Revenue, Current0.02.32.39.1
TOTAL CURRENT LIABILITIES7.28.810.120.9
Unearned Revenue, Non-Current--8.86.713.1
Deferred Tax Liability Non-Current----0.70.7
Other Non-Current Liabilities----1.61.8
TOTAL LIABILITIES7.217.619.136.6
Common Stock0.50.50.60.7
Additional Paid in Capital332.8339.8423.2534.5
Retained Earnings-253.2-275.5-302.1-328.5
Comprehensive Income and Other0.00.00.00.0
TOTAL COMMON EQUITY80.164.9121.7206.6
TOTAL EQUITY80.164.9121.7206.6
TOTAL LIABILITIES AND EQUITY87.382.5140.8243.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGMO:US $9.97 USD -0.19

SGMO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bluebird Bio Inc $163.21 USD +0.14
Fibrocell Science Inc $5.00 USD -0.27
View Industry Companies
 

Industry Analysis

SGMO

Industry Average

Valuation SGMO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 15.0x
Price/Book 3.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANGAMO BIOSCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.